FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL / / January 7, 2026 / Aspire Biopharma Holdings ...
Investing.com -- Aspire Biopharma Holdings Inc (NASDAQ:ASBP) stock surged 60.6% in premarket trading Wednesday after the ...
Aspire does not expect to conduct additional studies beyond its currently planned multicenter crossover clinical trial. ・The ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
ROUND ROCK, TX - January 12, 2026 - PRESSADVANTAGE - Texas Certified Restoration recently detailed a comprehensive ...
MANCHESTER, UNITED KINGDOM, January 7, 2026 /EINPresswire.com/ — Manchester-based activist rock band Alternative Influence ...
Company Successfully Executed Distribution of $500,000 in Cash and $500,000 in BONK Digital Assets Prior to Year-End; ...
Streams.AI for Microsoft Teams keeps users working inside Microsoft Teams while ensuring communications stay available ...
Andover moving company recognized for decade of excellence, transparent pricing, and commitment to stress-free ...
NEW YORK, NY, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — Ouros Jewels has announced the launch of its ...
Second-generation owner Robert D. Murphy acquires family-founded Custom Coach Creations, ensuring legacy craftsmanship ...